FarmaForum 2026

How can the safety and regulatory compliance of artificial intelligence (AI) solutions be ensured without limiting their potential for innovation? This will be one of the key questions addressed by GMV at the upcoming Farmaforum 2026.

As part of the Medical Devices Forum, Juan Carlos Sánchez Rosado, Health Business Executive at GMV, will speak on the panel “From AI to CE: Regulation in the age of AI. How to ensure safety and compliance without holding back innovation.” He will share GMV’s perspective and experience in developing AI technologies for healthcare and discuss how the industry can advance toward innovative, safe solutions that are equipped to meet the demands of the evolving regulatory landscape.

The session will bring together specialists in AI, medical devices, and regulation to examine one of the most pressing challenges currently facing healthcare technology: driving innovation while ensuring that solutions meet regulatory requirements for safety, quality, and compliance.

The integration of AI into medical devices is opening up new possibilities for improving diagnosis, supporting clinical decision-making, and streamlining healthcare delivery. It also poses new regulatory challenges, particularly when systems incorporate AI models that can evolve or exhibit more complex behavior than conventional software.

In this context, the experience of technology companies is essential to understanding how regulatory and safety requirements can be built into the earliest stages of development, ensuring that compliance does not become a barrier to innovation.